ReviewSensors (Basel, Switzerland)2012
Waveguide-mode sensors as aptasensors.
Review in Sensors (Basel, Switzerland), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Tau biosensor on aptamer-modified interdigitated electrode for monitoring neurological effect caused by anesthesia.Heliyon · 2024Article
- Review
- Nanowired dual-electrodes surface to monitor cerebral ischemia by current-volt measurements.3 Biotech · 2021Article
- Quantification of cortisol for the medical diagnosis of multiple pregnancy-related diseases.3 Biotech · 2020Article
- Coordinated Dispersion and Aggregation of Gold Nanorod in Aptamer-Mediated Gestational Hypertension Analysis.Journal of analytical methods in chemistry · 2019Article
- Characterization of Gold-Sputtered Zinc Oxide Nanorods-a Potential Hybrid Material.Nanoscale research letters · 2016Article
- Shape- and Size-Controlled Synthesis of Silver Nanoparticles Using Aloe vera Plant Extract and Their Antimicrobial Activity.Nanoscale research letters · 2016Article
- Aptamers in analytics.The Analyst · 2016Review
- Biotin-Streptavidin Competition Mediates Sensitive Detection of Biomolecules in Enzyme Linked Immunosorbent Assay.PloS one · 2016Article
- Biotechnological Aspects and Perspective of Microbial Keratinase Production.BioMed research international · 2015Review
- Colorimetric detection of controlled assembly and disassembly of aptamers on unmodified gold nanoparticles.Biosensors & bioelectronics · 2014Article
- Recent advances and achievements in nanomaterial-based, and structure switchable aptasensing platforms for ochratoxin A detection.Sensors (Basel, Switzerland) · 2013Article
- Strategies to characterize fungal lipases for applications in medicine and dairy industry.BioMed research international · 2013Review
- Observations of immuno-gold conjugates on influenza viruses using waveguide-mode sensors.PloS one · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aptamers are artificial nucleic acid ligands that can be generated by in vitro selection through partition and amplification. Aptamers can be generated against a wide range of biomolecules through the formation of versatile stem-loop structures. Because aptamers are potential substitutes for antibodies and drugs, the development of an aptamer-based sensor (aptasensor) is mandatory for diagnosis. We previously reported that waveguide-mode sensors are useful in the analysis of a wide range of biomolecular interactions, including aptamers. The advantages of the waveguide-mode sensor that we developed include physical and chemical stability and that higher sensitivity can be achieved with ease by perforating the waveguide layer or using colored materials such as dyes or metal nanoparticles as labels. Herein, we provide an overview of the strategies and applications for aptamer-based analyses using waveguide-mode sensors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.